Sweden· SE-20110706000090
DACOGEN 50 mg Pulver till koncentrat till infusionsvätska, lösning
A medicinal product containing decitabine, registered in Sweden by Janssen-Cilag International NV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Decitabine
- Manufacturer
- Janssen-Cilag International NV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20110706000090
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Decitabine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainDACOGEN 50 mg polvo para concentrado para solucion para perfusionJanssen-Cilag International N.V
- FinlandDacogenJanssen-Cilag International NV
- BelgiumDacogen 50 mgJanssen-Cilag International
- IrelandDacogen 50 mg powder for concentrate for solution for infusionJanssen-Cilag International NV
- NorwayDacogenJanssen-Cilag International N.V.
- United KingdomDacogen 50mg powder for concentrate for solution for infusion vialsJanssen-Cilag Ltd
- SwitzerlandDacogen
- IcelandDacogenJanssen-Cilag International NV*
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Decitabin Accord, Decitabine Ever Pharma
- Belgium · Decitabine Ever Pharma, Decitabine Hikma
- Bulgaria · Децитабин Ever Pharma
- Cyprus · Decitabine Accord, Decitabine Teva
- Denmark · Decitabin Teva, Decitabine "sandoz"
- Spain · Decitabina Accord, Decitabina Eugia
- Finland · Decitabine Ever Pharma
- United Kingdom (Northern Ireland) · Decitabine Hikma Farmacêutica (Portugal)
- Croatia · Decitabin Accord, Decitabine Ever Pharma
- Hungary · Decitabine Ever Pharma
- Ireland · Decitabine Accord, Decitabine Ever Pharma
- Iceland · Dacogen
- Italy · Decitabina Accord, Decitabina Aurobindo
- Liechtenstein · Dacogen
- Lithuania · Decitabine Accord, Decitabine Ever Pharma
- Latvia · Decitabine Ever Pharma
- Netherlands · Decitabine Ever Pharma, Decitabine Hikma
- Norway · Dacogen, Decitabin Teva
- Portugal · Decitabina Accord, Decitabina Eugia
- Romania · Decitabină Accord, Decitabină Sandoz
- Slovenia · Decitabin Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9ee64cc0-6c8c-4107-bd46-2caeeb5c44d2 GET /v1/drugs/9ee64cc0-6c8c-4107-bd46-2caeeb5c44d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20110706000090",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20110706000090",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/dacogen"
}See everything about decitabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.